N/A
Completed N=521
Pneumococcal Nasopharyngeal and Oropharyngeal Carriage in Adults
Preference, Patient
Source: ClinicalTrials.gov NCT04831788 ↗
Enrolled (actual)
521
Serious AEs
—
Results posted
Nov 2023
Primary outcomePrimary: Prevalence — 16 Participants
Summary
This is the first baseline pilot-study that will evaluate the NP and OP colonization with the underline of pneumococcal serotype distribution among adults older than 50 years of age in Serbia and Southeastern Europe. Results of this project will serve as additional evidence in order to increase coverage among adults and elderly
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Prevalence |
16 | — |
| SECONDARY Number of Participants With Spn Serotypes |
10; 6 | — |
Eligibility Criteria
Inclusion Criteria
- Adults older than 50 years of age visiting the Health Care Centre with or without signs of upper respiratory tract infection during the study period
Exclusion Criteria
- Living outside of Novi Sad, use of oral antibiotics in the two weeks prior to taking the swab and presence of a confirmed immunodeficiency (hematological malignancies, inherited immunodeficiency, HIV, post-splenectomy status, cancer chemotherapy).
Data sourced from ClinicalTrials.gov (NCT04831788). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.